KIMS Logo

KONASEEMA INSTITUTE OF MEDICAL SCIENCES AND RESEARCH FOUNDATION (KIMS)

Konaseema Institute of Medical Sciences (KIMS):

Advancing Equitable Cancer and Palliative Care through AI and Frugal Innovation

Konaseema Institute of Medical Sciences (KIMS), located in the coastal delta region of Andhra Pradesh, India, is the first and only medical college serving this geographically unique and socio-economically diverse community. The Konaseema region faces distinctive cancer risks high salt intake, occupational exposure to coconut pith and oil-rig by-products, and environmental pollutants resulting in an atypical burden of oral, breast, and biliary tract cancers.

KIMS has emerged as a pioneer in evidence-based, technology-enabled cancer control. Through translational research, community partnerships, and sustainable public-health integration, the institute is transforming the way rural populations access prevention, early detection, treatment, and palliative care.

The Ayuvu Command Center functions as a comprehensive platform for cancer emergency response and integrated care coordination. This model decentralizes expertise, minimizes patient travel, and ensures that oncologists focus on complex cases while community teams handle prevention and early intervention.

Cancer Emergency Management

24 × 7 helpline, real-time bed tracking, ambulance coordination, and tele-oncology support for emergencies such as febrile neutropenia, airway compromise, and tumor bleeding.

Patient Navigation

AI-powered dashboards track screened individuals, issue follow-up reminders, and schedule appointments across primary, secondary, and tertiary levels.

Data Integration

Seamless linkage with Oral Cancer AI and Breast Light devices allows remote monitoring and intelligent triage.

Health-System Synergy

Full integration with government insurance and public-health programs Ayushman Bharat, National Health Mission, and Arogyasree—to ensure cashless access and sustainability.

Evidence of Global Engagement

KIMS maintains a continuous relationship with the Union for International Cancer Control (UICC) spanning more than sixteen years.

UICC Travel Grant (2008):
Initiated KIMS’s global collaborations in cancer control.

UICC World Cancer Congress (Geneva 2024):
Presented two landmark studies

1. “AI-Enabled Mass Cancer Screening of 3 Lakh Women in Rural Konaseema” — the largest community-based AI screening initiative in India.
2. “Impact of Screening Education Programs on Awareness and Early-Detection Behavior” — demonstrating measurable improvements in cancer literacy and earlier stage at diagnosis.

Comprehensive Palliative and Hospice Care

Recognizing that effective cancer control extends beyond treatment, KIMS has developed a comprehensive palliative-care and hospice program that integrates clinical, educational, and community components. This holistic model highlighted at the European Association for Palliative Care Conference (EAPC Helsinki 2025)—demonstrates that compassionate, community-anchored care can coexist with cutting-edge innovation.

Three-Tiered Cancer-Care Delivery

KIMS has established an integrated, doorstep-to-tertiary continuum of care

Tier 1

Home & Community: AI screening, symptom relief, basic wound management, tele-consultation (ASHA workers, ANMs, trained volunteers)

Tier 2

Primary & Secondary Centers: Diagnostic follow-up, simple surgeries, chemotherapy for stable patients (RMPs, general physicians, nurses)

Tier 3

KIMS Tertiary Center: Complex oncologic surgeries, radiation therapy, advanced chemotherapy, clinical trials, hospice (Oncologists, multidisciplinary specialists)

Research, Registry, and Innovation

KIMS actively contributes to the National Cancer Registry Programme (NCRP) and is developing a regional registry to capture the unique epidemiology of Konaseema. The Medhankua Innovation Wing anchors ongoing R&D and patent filings including AI algorithms for oral and breast cancers, low-cost NPWT devices, tele-oncology platforms, and predictive analytics for treatment adherence.

International Collaboration Goals

To amplify its impact, KIMS seeks partnerships with IARC–WHO, PATH, Stanford AIMI, MIT Jameel Clinic, EAPC, IAHPC, Wellcome Trust, Grand Challenges Canada, and NCI Center for Global Health.

Cancer Focus Areas

Breast Cancer: Early detection using Breast Light; focus on women aged 30–50. Oral Cancer: AI screening of high-risk tobacco and areca-nut users. Biliary and Gastrointestinal Cancers: Ongoing research on regional risk factors and outcomes.

Impact and Vision

Through AI technology, frugal innovation, community networks, and palliative care, KIMS has improved screening, diagnosis, accessibility, affordability, and quality of life for cancer patients. KIMS envisions becoming a global reference center for equitable rural oncology.

Contact details

Dr A. V. S. Suresh Attili

MD, DM, PDCR, ECMO

Consultant Medical Oncologist & Hematologist
Konaseema Institute of Medical Sciences (KIMS)

Search here

Search for Courses, Hospital,& other Information.